How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

How SARS-CoV-2 Will Catalyze Decentralized Testing

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

How COVID-19 Could Impact Digital Health

e-Health in France: Spotlight on the National Healthcare Digitalization Strategy

Reflecting on the 17th Annual HBS Healthcare Conference

Bridging the Gap in Clinical and Economic Evidence for Digital Health Tech in the UK

E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System

The Opportunity for Real-World Data and Evidence in Ophthalmology

Amazon’s Healthcare Strategy Hinges on Data

E-Health in Germany: Rapid Progression of Digitalisation?

Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies

Putting Cerner’s Big Investment in Lumeris Into Strategic Context

Scaling the Mountain: Adoption Strategy for Digital Health

Three Models for Population Health Technology

Seattle’s Journey to the Summit of Cancer Commercialization

The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies

Why Flatiron’s Big Exit May Not Be the Boon for Digital Health That Some Expect

PART 3: What’s Next in 2018? Advanced Therapeutics – Gene Therapy, CAR-T, and Microbiome

Health Advances Blog

Category: Health IT and Digital Health

How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

How SARS-CoV-2 Will Catalyze Decentralized Testing

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

How COVID-19 Could Impact Digital Health

e-Health in France: Spotlight on the National Healthcare Digitalization Strategy

Reflecting on the 17th Annual HBS Healthcare Conference

Bridging the Gap in Clinical and Economic Evidence for Digital Health Tech in the UK

E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System

The Opportunity for Real-World Data and Evidence in Ophthalmology

Amazon’s Healthcare Strategy Hinges on Data

E-Health in Germany: Rapid Progression of Digitalisation?

Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies

Putting Cerner’s Big Investment in Lumeris Into Strategic Context

Scaling the Mountain: Adoption Strategy for Digital Health

Three Models for Population Health Technology

Seattle’s Journey to the Summit of Cancer Commercialization

The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies

Why Flatiron’s Big Exit May Not Be the Boon for Digital Health That Some Expect

PART 3: What’s Next in 2018? Advanced Therapeutics – Gene Therapy, CAR-T, and Microbiome